A prominent group, the biotechnology industry of Galicia has actively participated in BioSpain 2023, one of the most important events in the biotechnology sector in Europe, which takes place in Barcelona from September 26 to 28. This event is being organized by the Spanish Association of Bioenterprises (Asebio)in collaboration with Biocat.
the president of Bioga, José Manuel López Vilariño, highlighted the importance of the Galician presence at BioSpain 2023, with the aim of internationalizing its innovative approach and establishing strategic alliances for pioneering projects, as well as to explore new business opportunities. Galicia has stood out as a bioentrepreneurship region, having created nine biotechnology companies in 2022, making it the second most active autonomous community in this field in Spain.
“Galician companies are key actors in the biotechnology revolution, and that is why we are in forums such as BioSpain 2023, where strategies are discussed to address the challenges of current and future diseases, as well as the financing avenues necessary to continue growing,” he stressed. the president of Bioga.
The Galician delegation at BioSpain 2023, under the institutional brand “Galicia Bio”, is composed of the Xunta de Galicia, Galician Innovation Agency, Health Knowledge Agency, XesGalicia, Bioga, Galicia Health Cluster, University of Santiago de Compostela, University of A Coruña and University of Vigo. At Fira de Barcelona all the partners of the Business Technology Cluster of Life Sciences of those who have participated Zendal, Biopolo Sionlla, Diversa Technologies, i-Grape Laboratory, Celtarys Research, BFlow, Anfaco-Cecopesca and SATIN, along with 20 other key players in the field of biotechnology.
BioSpain is one of the leading conferences in Europe that brings together more than 850 innovative organizations working in areas such as health, sustainable agriculture and solutions to combat climate change. This event has had the participation of more than 1,500 professionals from 30 countries, more than 200 exhibitors and more than 50 investors with more than 3,500 meetings, the objective of promoting innovation, investment, collaboration and business opportunities has been achieved. business in the field of biotechnology.
